Product
Dengue 1,2,3,4 vaccine
1 clinical trial
1 indication
Indication
DengueClinical trial
Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Immunogenicity of the Dengue 1, 2, 3, 4 (Attenuated) Vaccine From Instituto ButantanStatus: Active (not recruiting), Estimated PCD: 2021-07-13